| 摘要 |
<p>The present invention relates to the therapeutic use of molecules which bind and neutralize IFN-Ϝ in primates. More specifically, the present invention relates to the use of an anti-primate IFN-Ϝ antibody for preventing or treating diseases wherein IFN-Ϝ is pathogenic. The present invention further relates to a pharmaceutical composition comprising the anti-primate IFN-Ϝ antibody D9D10 for preventing or treating pathological reactions caused by IFN-Ϝ.</p> |
